Skip to main content

Cerevel Therapeutics Holdings, Inc. - Common Stock (NQ: CERE )

44.96 UNCHANGED
Last Price Updated: 4:15 PM EDT, Jul 31, 2024 Add to My Watchlist

Other Filings

Form S-1
Source: SEC/Edgar
January 23, 2014
Form 8-K
Source: SEC/Edgar
January 23, 2014
Form CT ORDER
Source: SEC/Edgar
January 12, 2014
Form 8-K
Source: SEC/Edgar
January 08, 2014
Form PRE 14A
Source: SEC/Edgar
December 26, 2013
Form 8-K
Source: SEC/Edgar
December 25, 2013
Form 8-K
Source: SEC/Edgar
November 20, 2013
Form 8-K
Source: SEC/Edgar
October 17, 2013
Form SC 13G/A
Source: SEC/Edgar
September 09, 2013
Form 8-K
Source: SEC/Edgar
July 10, 2013
Form 8-K
Source: SEC/Edgar
June 19, 2013
Form 8-K
Source: SEC/Edgar
April 10, 2013
Form SC 13G
Source: SEC/Edgar
February 13, 2013
Form SC 13G
Source: SEC/Edgar
February 13, 2013
Form SC 13G
Source: SEC/Edgar
February 13, 2013
Form SC 13G
Source: SEC/Edgar
February 13, 2013
Form SC 13G
Source: SEC/Edgar
February 12, 2013
Form 8-K
Source: SEC/Edgar
February 12, 2013
Form SC 13G
Source: SEC/Edgar
February 10, 2013
Form DEF 14A
Source: SEC/Edgar
January 10, 2013
Form ARS
Source: SEC/Edgar
January 10, 2013
Form 8-K
Source: SEC/Edgar
January 09, 2013
Form CT ORDER
Source: SEC/Edgar
January 03, 2013
Form 8-K
Source: SEC/Edgar
November 19, 2012
Form 3/A
Source: SEC/Edgar
October 11, 2012
Form 8-K
Source: SEC/Edgar
October 10, 2012
Form CT ORDER
Source: SEC/Edgar
September 04, 2012
Form 8-K
Source: SEC/Edgar
August 21, 2012
Form 8-K
Source: SEC/Edgar
August 19, 2012
Form DEF 14A
Source: SEC/Edgar
July 19, 2012
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.